论文部分内容阅读
选取本院2015年1月至2015年12月的120例T_2DM患者,随机分两组各60例。对照组给予格列喹酮;研究组给予格列美脲。结果:研究组血糖指标优于对照组(P<0.05)。结论:格列美脲治疗T_2DM的效果较好、安全性高。
A total of 120 T 2DM patients from January 2015 to December 2015 in our hospital were randomly divided into two groups of 60 patients. The control group was given gliquidone; the study group was given glimepiride. Results: The study group was better than the control group (P <0.05). Conclusion: Glimepiride treatment of T 2 DM is better and more safe.